We are live on ! Find out more
TVTX icon

Travere Therapeutics
TVTX

169 hedge funds and large institutions have $2.03B invested in Travere Therapeutics in 2021 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 16

100% more funds holding in top 10

Funds holding in top 10: 4 → 8 (+4)

37% more capital invested

Capital invested by funds: $1.48B → $2.03B (+$549M)

14% more funds holding

Funds holding: 148 → 169 (+21)

7.37% more ownership

Funds ownership: 100.28% → 107.65% (+7.4%)

0% more call options, than puts

Call options by funds: $5.27M | Put options by funds: $5.26M

0% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 50

Holders
169
Holders Change
+21
Holders Change %
+14.19%
% of All Funds
2.6%
Holding in Top 10
8
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+100%
% of All Funds
0.12%
New
39
Increased
50
Reduced
50
Closed
16
Calls
$5.27M
Puts
$5.26M
Net Calls
+$7K
Net Calls Change
-$1.1M

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$42.3M
2
BBA
Baker Bros. Advisors
New York
+$17.7M
3
SI
Sofinnova Investments
California
+$17M
4
Invesco
Invesco
Georgia
+$13.4M
5
VA
VR Adviser
New York
+$7.4M

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$18.9M
2
RSCM
Rock Springs Capital Management
Maryland
-$15.4M
3
Bank of America
Bank of America
North Carolina
-$12.5M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$11.2M
5
CAM
Cormorant Asset Management
Massachusetts
-$8.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS AM
76
UBS AM
Illinois
$1.96M +$321K +11,413 +22%
Tudor Investment Corp
77
Tudor Investment Corp
Connecticut
$1.94M +$162K +5,757 +10%
Wells Fargo
78
Wells Fargo
California
$1.88M +$403K +14,319 +31%
Allianz Asset Management
79
Allianz Asset Management
Germany
$1.85M +$1.68M +59,820 New
AllianceBernstein
80
AllianceBernstein
Tennessee
$1.84M – – –
ACM
81
AlphaCrest Capital Management
New York
$1.73M +$1.57M +55,791 New
PI
82
Putnam Investments
Massachusetts
$1.71M +$1.55M +55,046 New
DekaBank Deutsche Girozentrale
83
DekaBank Deutsche Girozentrale
Germany
$1.69M -$369K -13,100 -19%
HS
84
HighVista Strategies
Massachusetts
$1.68M -$73K -2,591 -5%
Federated Hermes
85
Federated Hermes
Pennsylvania
$1.59M +$1.35M +47,971 +1,527%
EIM
86
Essex Investment Management
Massachusetts
$1.56M +$1.42M +50,301 New
AAA
87
Affinity Asset Advisors
New York
$1.55M -$4.22M -150,000 -75%
NFGH
88
Nan Fung Group Holdings
Hong Kong
$1.5M +$1.37M +48,500 New
Two Sigma Advisers
89
Two Sigma Advisers
New York
$1.48M +$1.34M +47,700 New
CS
90
Credit Suisse
Switzerland
$1.43M +$174K +6,172 +15%
Fisher Asset Management
91
Fisher Asset Management
Washington
$1.37M +$449K +15,938 +57%
New York State Common Retirement Fund
92
New York State Common Retirement Fund
New York
$1.34M +$111K +3,945 +10%
Walleye Capital
93
Walleye Capital
New York
$1.34M +$1.21M +43,095 New
ECM
94
ExodusPoint Capital Management
New York
$1.21M +$1.1M +39,120 New
JCIA
95
Jackson Creek Investment Advisors
Colorado
$1.18M +$1.07M +38,089 New
Allspring Global Investments
96
Allspring Global Investments
North Carolina
$1.17M +$1.06M +37,756 New
EAM
97
Erste Asset Management
Austria
$1.09M – – –
E
98
Ergoteles
New York
$1.05M +$955K +33,898 New
AIG
99
American International Group
New York
$974K -$15K -532 -2%
SG Americas Securities
100
SG Americas Securities
New York
$951K -$551K -19,553 -39%
2 3
4
5 6

TVTX Hedge Fund Activity: Q4 2021 in Review

169 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Travere Therapeutics (TVTX) for Q4 2021, worth a combined $2.03B — up 37% from $1.48B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new TVTX positions and 16 closed out — a net gain of 23 holders — while 50 added to existing stakes and 50 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $42.3M. The largest seller was Armistice Capital, cutting an estimated $18.9M.

  • 169 institutional investors held Travere Therapeutics (TVTX) as of Q4 2021, up from 148 in Q3 2021.
  • Funds reported $2.03B of Travere Therapeutics stock for Q4 2021, up 37% quarter-over-quarter.
  • 39 funds opened new Travere Therapeutics positions in Q4 2021 and 16 closed out, a net change of +23 holders.
  • The largest Travere Therapeutics buyer in Q4 2021 was Goldman Sachs, an estimated $42.3M added.
  • The largest Travere Therapeutics seller in Q4 2021 was Armistice Capital, an estimated $18.9M sold.

Based on aggregated 13F filings for Q4 2021.